Brief: Lisata Therapeutics Q3 EPS USD -0.65
02/11/2023 21:45
Nov 2 (Reuters) - Lisata Therapeutics Q3 operating expenses USD 5.964 million. * Q3 operating income USD -5.964 million * Q3 EPS USD -0.65 * Q3 net income USD -5.261 million
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal